138 related articles for article (PubMed ID: 7840787)
1. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
Lawrence DM; Joseph DB; Bidlack JM
Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
[TBL] [Abstract][Full Text] [Related]
2. Chronic opioid treatment of the mouse thymoma cell lines R1.G1 and R1EGO leads to down-regulation of the kappa opioid receptor without desensitization of adenylyl cyclase activity.
Martin-Kleiner I; Bidlack JM
Int Immunopharmacol; 2001 Jan; 1(1):13-20. PubMed ID: 11367510
[TBL] [Abstract][Full Text] [Related]
3. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
4. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
5. Kappa opioid receptors on three related thymoma cell lines. Differences in receptor-effector coupling.
Bidlack JM; Joseph DB; Lawrence DM
Adv Exp Med Biol; 1995; 373():23-7. PubMed ID: 7668156
[No Abstract] [Full Text] [Related]
6. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
7. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
8. Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression.
Hirst RA; Hirota K; Grandy DK; Lambert DG
Neurosci Lett; 1997 Aug; 232(2):119-22. PubMed ID: 9302101
[TBL] [Abstract][Full Text] [Related]
9. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
[TBL] [Abstract][Full Text] [Related]
10. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.
Konkoy CS; Childers SR
Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptors are differentially labeled by arylacetamides and benzomorphans.
Rusovici DE; Negus SS; Mello NK; Bidlack JM
Eur J Pharmacol; 2004 Feb; 485(1-3):119-25. PubMed ID: 14757131
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
[TBL] [Abstract][Full Text] [Related]
14. The kappa-opioid agonist U-69593 affects intracellular calcium level in R1.1 mouse thymoma cell line.
Martin-Kleiner I; Gabrilovac J
Int Immunopharmacol; 2002 Jun; 2(7):975-80. PubMed ID: 12188038
[TBL] [Abstract][Full Text] [Related]
15. The synthetic kappa-opioid agonist (-)U50,488 does not affect calcium transport into R1.1 mouse thymoma cell line.
Martin-Kleiner I; Bidlack JM
Int J Immunopharmacol; 1999 Feb; 21(2):133-40. PubMed ID: 10230876
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of the adenylyl cyclase system in cloned kappa-opioid receptor-transfected cells following sustained agonist treatment: A chimeric study using G protein alpha(i)2/alpha(q) subunits.
Nakagawa T; Ozawa T; Watanabe T; Minami M; Satoh M
Jpn J Pharmacol; 1999 Dec; 81(4):353-61. PubMed ID: 10669040
[TBL] [Abstract][Full Text] [Related]
17. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
Devlin T; Shoemaker WJ
J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
[TBL] [Abstract][Full Text] [Related]
18. The kappa-opioid receptor expressed on the mouse lymphoma cell line R1.1 contains a sulfhydryl group at the binding site.
Joseph DB; Bidlack JM
Eur J Pharmacol; 1994 Mar; 267(1):1-6. PubMed ID: 8206123
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
Zhang WM; Jin WQ; Wong TM
J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942
[TBL] [Abstract][Full Text] [Related]
20. kappa-Opioid binding sites on a murine lymphoma cell line.
Bidlack JM; Saripalli LD; Lawrence DM
Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
